Keenova to Participate in the Jefferies Global Healthcare Conference in London

Keenova Therapeutics (NASDAQ:MNK) announced management will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

Rhea-AI Summary

Keenova Therapeutics (NASDAQ:MNK) announced management will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 10:00 a.m. GMT (5:00 a.m. ET). A live webcast and archived replay will be available via the company’s Investor Relations website at www.keenova.com.

The presentation provides investors a scheduled opportunity to hear management commentary and view the webcast recording.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 10:00 a.m. Greenwich Mean Time (GMT) (5:00 a.m. ET).

A live and archived webcast of the event may be accessed through the Investor Relations section of the Company's website at www.keenova.com.

About Keenova

Keenova Therapeutics is a leading global developer and manufacturer of branded therapeutics that strives to help patients with rare or unaddressed conditions live happier and healthier lives.

The Company's diversified brands portfolio is focused across a wide range of therapeutic areas of significant unmet need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with facilities in Louisiana, New Jersey, New York, Pennsylvania and Wisconsin. To learn more, please visit www.keenova.com.

Keenova uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission ("SEC") disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

Contacts

Investors 
Juan Avendano
avendano.juan@endo.com

Media 
Linda Huss
huss.linda@endo.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Keenova (MNK) present at the Jefferies Global Healthcare Conference in London?

Keenova will present on Wednesday, November 19, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).

How can investors watch the Keenova (MNK) presentation at Jefferies Global Healthcare Conference?

Investors can view a live webcast and later access an archived replay via Keenova's Investor Relations website at www.keenova.com.

Will the Keenova (MNK) Jefferies presentation be available after the live event?

Yes. An archived webcast replay will be available on the company's Investor Relations website after the live presentation.

What time is the Keenova (MNK) presentation for viewers in New York (ET)?

The presentation at 10:00 a.m. GMT is 5:00 a.m. ET for viewers in New York.

Where on Keenova's site will the Jefferies conference webcast be posted?

The webcast will be posted in the Investor Relations section of Keenova's website at www.keenova.com.

Is the Jefferies Global Healthcare Conference presentation by Keenova (MNK) open to the public?

The presentation is accessible via the company's public Investor Relations webcast link on www.keenova.com.